Ziconotide as First-Line IDT
Is a
Allocation Type
NA
0
Participating Facility
Health Conditions in Trial
Intervention Model
Single Group Assignment
0
Intervention Name
Quantitative sensory testing
0
Ziconotide 100 MCG(microgram)/ML Intrathecal Solution
0
Serum markers: Interleukin-1, Interleukin-6, and tumor necrosis factor
0
Interventional Trial Phase
Phase 4
0
Interventional Trial Purpose
Treatment
0
Intervention Type
Diagnostic Test
0
Drug
0
Last Updated
January 12, 2021
0
Masking Type
None (Open Label)
0
Primary Completion Date
August 30, 2020
0
Trial Recruitment Size
13
0
Trial Sponsor
Clinical Trial Start Date
November 3, 2016
0
Study Completion Date
December 30, 2020
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
Prospective Study of Conservative Ziconotide Dosing as a First-Line Intrathecal Drug Therapy for Neuropathic Pain
0
Official Website
Find more entities like Ziconotide as First-Line IDT
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.